删除或更新信息,请邮件至freekaoyan#163.com(#换成@)

Application of expression genomics in drug development and genomic medicine (2004)_香港中文大学

香港中文大学 辅仁网/2017-06-27

Application of expression genomics in drug development and genomic medicine
Publication in refereed journal


香港中文大学研究人员 ( 现职)
锺国衡教授 (妇产科学系)
杨明明教授 (肿瘤学系)
王益夫教授 (妇产科学系)


全文


引用次数
Web of Sciencehttp://aims.cuhk.edu.hk/converis/portal/Publication/4WOS source URL

其它资讯

摘要Expressed sequence tags and genome sequencing have virtually uncovered all the genes and transcripts in the human genome. Functional genomic analysis of these genes will undoubtedly reveal their physiological roles in cells in the near future. Coupled with the advent of DNA microarray, cellular response to perturbation can now be examined at genome-wide levels in a single analysis, yielding clues to the network of pathways and interacting pathways that underlie a comprehensive systems response to exposure to small molecule perturbants. This post-genomic information will be the foundation for knowledge-based in silico systems biology. It is envisioned that querying such relational databases will generate testable hypotheses as well as revealing information on networks of regulatory genes and pathways that could further fuel and shape molecular and drug target discovery, and ushering in a new era in genomic medicine. In this review, we will first discuss examples of laboratory results generated from high-throughput microarray analyses that illuminated previously unrecognized networks of regulatory genes and pathways that point to the mechanisms of action for the tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate, and the green tea polyphenol, epi-gallocatechin gallate. We will then focus on the application of gene expression profiles in genomic medicine for predicting treatment response in cancer, using clinical specimens obtained from patients. These studies and others point to an increasing trend in modern biology in which high-throughput genome scale comprehensive biological information is incorporated into databases for constructing and reconstructing pathways and networks of interacting pathways that constitute a physiological response to environmental perturbation at the organism or systems levels. (C) 200http://aims.cuhk.edu.hk/converis/portal/Publication/4 Wiley-Liss, Inc.

着者Chin KV, Selvanayagam ZE, Vittal R, Kita T, Kudoh K, Yang CS, Wong YF, Cheung TH, Yeo W, Chung TKH, Lin Y, Liao J, Shih JWC, Yap SF, Lin AW
期刊名称Drug Development Research
出版年份200http://aims.cuhk.edu.hk/converis/portal/Publication/4
月份6
日期1
卷号62
期次2
出版社WILEY-BLACKWELL
页次12http://aims.cuhk.edu.hk/converis/portal/Publication/4 - 133
国际标準期刊号0272-http://aims.cuhk.edu.hk/converis/portal/Publication/4391
电子国际标準期刊号1098-2299
语言英式英语

关键词genomic medicine; microarray; personalized; predictive; systems biology
Web of Science 学科类别Chemistry, Medicinal; CHEMISTRY, MEDICINAL; Pharmacology & Pharmacy; PHARMACOLOGY & PHARMACY

相关话题/国际 妇产科 语言 电子 学科